Six months into a campaign to rout out corruption from the Chinese healthcare industry, many of the underlying issues in the sector remain unchanged.
Surgeons operate on a patient in Chongqing, China, August 18, 2023. Credit: Costfoto/NurPhoto via Getty Images
Last summer, China’s ongoing corruption crackdown found a new target: the healthcare sector.
In an effort to lower medical costs at a time of slowing economic growth, the Chinese government targeted unscrupulous doctors, hospital officials, and pharmaceutical executives.
By mid-August, more than 170 hospital administrators were under investigation, according to state media, a dozen Chinese healthcare companies had withdrawn IPO plans, and $142 billion worth of value in Chinese heal
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Between Chinese encroachments in Taiwan and Taiwan's military spending spree, it can certainly feel like the drums of war are beating in East Asia. And yet, American investment into Taiwan continues to rise steadily. Are American multinationals prepared?
The political scientist explains how China has risen not just by following in the U.S.’s footsteps, but also by exploiting U.S. vulnerabilities and its own competitive advantages.
On-Demand Webinar: Strategies for Identifying Military End Users
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
